Skip to main content

Extended HPV Genotyping to Compare HPV Type Distribution in Self- and Provider-Collected Samples for Cervical Cancer Screening.

Publication ,  Journal Article
Rohner, E; Edelman, C; Sanusi, B; Schmitt, JW; Baker, A; Chesko, K; Faherty, B; Gregory, SM; Romocki, LS; Sivaraman, V; Nelson, JAE; Smith, JS ...
Published in: Cancer Epidemiol Biomarkers Prev
December 2020

BACKGROUND: Primary high-risk human papillomavirus (hr-HPV) testing of self-collected cervico-vaginal swabs could increase cervical cancer screening coverage, although triage strategies are needed to reduce unnecessary colposcopies. We evaluated the use of extended hr-HPV genotyping of self-collected samples for cervical cancer screening. METHODS: We recruited women ages 25-65 years at two colposcopy clinics in North Carolina between November 2016 and January 2019, and obtained self-collected cervico-vaginal samples, provider-collected cervical samples, and cervical biopsies from all enrolled women. Self- and provider-collected samples were tested for 14 hr-HPV genotypes using the Onclarity Assay (Becton Dickinson). We calculated hr-HPV genotype-specific prevalence and assessed agreement between results in self- and provider-collected samples. We ranked the hr-HPV genotypes according to their positive predictive value (PPV) for the detection of cervical intraepithelial neoplasia (CIN) grade 2 or higher (CIN2+). RESULTS: A total of 314 women participated (median age, 36 years); 85 women (27%) had CIN2+. More women tested positive for any hr-HPV on self-collected (76%) than on provider-collected samples (70%; P = 0.009) with type-specific agreement ranging from substantial to almost perfect. HPV-16 was the most common genotype in self-collected (27%) and provider-collected samples (20%), and HPV-16 prevalence was higher in self- than provider-collected samples (P < 0.001). In self- and provider-collected samples, HPV-16 had the highest PPV for CIN2+ detection. CONCLUSIONS: Overall sensitivity for CIN2+ detection was similar for both sample types, but the higher HPV-16 prevalence in self-collected samples could result in increased colposcopy referral rates. IMPACT: Additional molecular markers might be helpful to improve the triage of women who are hr-HPV positive on self-collected samples.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Cancer Epidemiol Biomarkers Prev

DOI

EISSN

1538-7755

Publication Date

December 2020

Volume

29

Issue

12

Start / End Page

2651 / 2661

Location

United States

Related Subject Headings

  • Uterine Cervical Neoplasms
  • Middle Aged
  • Humans
  • Human papillomavirus 16
  • Genotype
  • Female
  • Epidemiology
  • Early Detection of Cancer
  • Aged
  • Adult
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rohner, E., Edelman, C., Sanusi, B., Schmitt, J. W., Baker, A., Chesko, K., … Smith, J. S. (2020). Extended HPV Genotyping to Compare HPV Type Distribution in Self- and Provider-Collected Samples for Cervical Cancer Screening. Cancer Epidemiol Biomarkers Prev, 29(12), 2651–2661. https://doi.org/10.1158/1055-9965.EPI-20-0674
Rohner, Eliane, Claire Edelman, Busola Sanusi, John W. Schmitt, Anna Baker, Kirsty Chesko, Brian Faherty, et al. “Extended HPV Genotyping to Compare HPV Type Distribution in Self- and Provider-Collected Samples for Cervical Cancer Screening.Cancer Epidemiol Biomarkers Prev 29, no. 12 (December 2020): 2651–61. https://doi.org/10.1158/1055-9965.EPI-20-0674.
Rohner E, Edelman C, Sanusi B, Schmitt JW, Baker A, Chesko K, et al. Extended HPV Genotyping to Compare HPV Type Distribution in Self- and Provider-Collected Samples for Cervical Cancer Screening. Cancer Epidemiol Biomarkers Prev. 2020 Dec;29(12):2651–61.
Rohner, Eliane, et al. “Extended HPV Genotyping to Compare HPV Type Distribution in Self- and Provider-Collected Samples for Cervical Cancer Screening.Cancer Epidemiol Biomarkers Prev, vol. 29, no. 12, Dec. 2020, pp. 2651–61. Pubmed, doi:10.1158/1055-9965.EPI-20-0674.
Rohner E, Edelman C, Sanusi B, Schmitt JW, Baker A, Chesko K, Faherty B, Gregory SM, Romocki LS, Sivaraman V, Nelson JAE, O’Connor S, Hudgens MG, Knittel AK, Rahangdale L, Smith JS. Extended HPV Genotyping to Compare HPV Type Distribution in Self- and Provider-Collected Samples for Cervical Cancer Screening. Cancer Epidemiol Biomarkers Prev. 2020 Dec;29(12):2651–2661.

Published In

Cancer Epidemiol Biomarkers Prev

DOI

EISSN

1538-7755

Publication Date

December 2020

Volume

29

Issue

12

Start / End Page

2651 / 2661

Location

United States

Related Subject Headings

  • Uterine Cervical Neoplasms
  • Middle Aged
  • Humans
  • Human papillomavirus 16
  • Genotype
  • Female
  • Epidemiology
  • Early Detection of Cancer
  • Aged
  • Adult